"Oct. 17, 2012 -- Some antidepressants are linked to a slight increased risk of bleeding stroke, according to a new analysis.
Researchers looked at 16 published studies that included more than 500,000 people.
They focused o"...
Viibryd Patient Information including How Should I Take
In this Article
- What is vilazodone (Viibryd)?
- What are the possible side effects of vilazodone (Viibryd)?
- What is the most important information I should know about vilazodone (Viibryd)?
- What should I discuss with my healthcare provider before taking vilazodone (Viibryd)?
- How should I take vilazodone (Viibryd)?
- What happens if I miss a dose (Viibryd)?
- What happens if I overdose (Viibryd)?
- What should I avoid while taking vilazodone (Viibryd)?
- What other drugs will affect vilazodone (Viibryd)?
- Where can I get more information?
What should I discuss with my healthcare provider before taking vilazodone (Viibryd)?
Do not use vilazodone if you have used an MAO inhibitor such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.
You must wait at least 14 days after stopping an MAO inhibitor before you can take vilazodone. After you stop taking vilazodone, you must wait at least 14 days before you start taking an MAOI.
Tell your doctor about all other antidepressants you take, especially Celexa, Cymbalta, Desyrel, Effexor, Lexapro, Luvox, Oleptro, Prozac, Sarafem, Symbyax, Paxil, Pexeva, or Zoloft.
To make sure you can safely take vilazodone, tell your doctor if you have any of these other conditions:
- liver or kidney disease;
- a bleeding or blood clotting disorder;
- seizures or epilepsy;
- bipolar disorder (manic depression); or
- a history of drug abuse or suicidal thoughts.
Your family or other caregivers should also be alert to changes in your mood or symptoms. Your doctor will need to check you at regular visits for the first few months of treatment, or whenever your dose is changed.
You may have thoughts about suicide while taking an antidepressant, especially if you are younger than 24 years old. Tell your doctor if you have worsening depression or suicidal thoughts during the first several weeks of treatment, or whenever your dose is changed.
FDA pregnancy category C. Tell your doctor right away if you become pregnant while taking this medication. Vilazodone may cause heart defects or serious lung problems in a newborn if you take the medication during pregnancy. However, you may have a relapse of depression if you stop taking your antidepressant. Do not start or stop taking vilazodone during pregnancy without your doctor's advice.
It is not known whether vilazodone passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.
Do not give this medication to anyone under 18 years old without medical advice.
How should I take vilazodone (Viibryd)?
Take exactly as prescribed by your doctor. Do not take in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label. Your doctor may occasionally change your dose to make sure you get the best results.
Vilazodone works best if you take it with food.
It may take several weeks or months before your symptoms improve. Keep using the medication as directed and tell your doctor if your symptoms do not improve, or if they get worse.
Do not stop using vilazodone suddenly, or you could have unpleasant withdrawal symptoms. Ask your doctor how to avoid withdrawal symptoms when you stop using vilazodone.
Store at room temperature away from moisture and heat.
Additional Viibryd Information
- Viibryd Drug Interactions Center: vilazodone oral
- Viibryd Side Effects Center
- Viibryd FDA Approved Prescribing Information including Dosage
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get tips on therapy and treatment.